Volatility Shares Trust 2x Ether ETF

iShares Ethereum Trust ETF

Direxion Daily TSLA Bull 1.5X Shares

MicroSectors Gold Miners 3X Leveraged ETN

ProShares Ultra Bloomberg Natural Gas

Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily Gold Miners Bull 3X ETF

Global X Silver Miners ETF

United States Natural Gas

VanEck Vectors Junior Gold Miners ETF

T-REX 2X Inverse Tesla Daily Target ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

ProShares UltraShort Bloomberg Natrl Gas

GraniteShares 1.5x Long Coinbase Daily ETF

Direxion Daily Gold Miners Bear 3X ETF

Direxion Daily S&P Biotech Bull 3X ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Direxion Daily Semicondct Bear 3X ETF

ProShares UltraShort Silver

SPDR S&P Biotech ETF

Shuttle Pharmaceuticals Holdings Inc. Common Stock

Zapp Electric Vehicles Group Limited Ordinary Shares

Siyata Mobile Inc. Common Shares

ZK International Group Co. Ltd Ordinary Share

Nuvve Holding Corp. Common Stock

TTEC Holdings Inc. Common Stock

Marwynn Holdings Inc. Common stock

nLIGHT Inc. Common Stock

Insulet Corporation Common Stock

Rumble Inc. Class A Common Stock

Twin Vee PowerCats Co. Common Stock

Affirm Holdings Inc. Class A Common Stock

Theriva Biologics Inc. Common Stock

Ryman Hospitality Properties Inc. (REIT)

TeraWulf Inc. Common Stock

MicroAlgo Inc. Ordinary Shares

Alnylam Pharmaceuticals Inc. Common Stock

PNC Financial Services Group Inc. (The) Common Stock

Classover Holdings Inc. Class B Common Stock

Primerica Inc. Common Stock

Click here to get full coverage on Iovance Biotherapeutics Inc (IOVA) Q1 2025 Earnings Call Highlights: Strong Revenue from Antagy ... - Yahoo Finance

Iovance Biotherapeutics Inc (IOVA) Q1 2025 Earnings Call Highlights: Strong Revenue from Antagy ...  Yahoo Finance

Iovance Biotherapeutics Inc (IOVA) Q1 2025 Earnings Call Highlights: Strong Revenue from Antagy ... - Yahoo Finance

Click here to get full coverage on No Excuses, Iovance Biotherapeutics' Amtagvi Launch Has Underperformed (NASDAQ:IOVA) - Seeking Alpha

No Excuses, Iovance Biotherapeutics' Amtagvi Launch Has Underperformed (NASDAQ:IOVA)  Seeking Alpha

No Excuses, Iovance Biotherapeutics' Amtagvi Launch Has Underperformed (NASDAQ:IOVA) - Seeking Alpha

Click here to get full coverage on Iovance Biotherapeutics Stock Sinks 46%. Here’s Why the Biotech Is Tumbling. - Barron's

Iovance Biotherapeutics Stock Sinks 46%. Here’s Why the Biotech Is Tumbling.  Barron's

Iovance Biotherapeutics Stock Sinks 46%. Here’s Why the Biotech Is Tumbling. - Barron's

Click here to get full coverage on Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025 - GlobeNewswire

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025  GlobeNewswire

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025 - GlobeNewswire

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates  Yahoo Finance

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Expert Outlook: Iovance Biotherapeutics Through The Eyes Of 9 Analysts - Benzinga

Expert Outlook: Iovance Biotherapeutics Through The Eyes Of 9 Analysts  Benzinga

Expert Outlook: Iovance Biotherapeutics Through The Eyes Of 9 Analysts - Benzinga

Click here to get full coverage on Why Iovance Biotherapeutics Stock Is Crashing Today - The Motley Fool

Why Iovance Biotherapeutics Stock Is Crashing Today  The Motley Fool

Why Iovance Biotherapeutics Stock Is Crashing Today - The Motley Fool

Click here to get full coverage on Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation  Business Wire

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates - MSN

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates  MSN

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates - MSN

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Sees Increased Options Activity A - GuruFocus

Iovance Biotherapeutics (IOVA) Sees Increased Options Activity A  GuruFocus

Iovance Biotherapeutics (IOVA) Sees Increased Options Activity A - GuruFocus

Click here to get full coverage on Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire

Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz  Business Wire

Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire

Click here to get full coverage on Iovance Biotherapeutics: Q1 Earnings Snapshot - New Haven Register

Iovance Biotherapeutics: Q1 Earnings Snapshot  New Haven Register

Iovance Biotherapeutics: Q1 Earnings Snapshot - New Haven Register

Click here to get full coverage on Iovance stock falls after guidance cut, Q1 miss (IOVA:NASDAQ) - Seeking Alpha

Iovance stock falls after guidance cut, Q1 miss (IOVA:NASDAQ)  Seeking Alpha

Iovance stock falls after guidance cut, Q1 miss (IOVA:NASDAQ) - Seeking Alpha

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Stock Rating Maintained, Price Target Lowered by Chardan Capital | IOVA Stock News - GuruFocus

Iovance Biotherapeutics (IOVA) Stock Rating Maintained, Price Target Lowered by Chardan Capital | IOVA Stock News  GuruFocus

Iovance Biotherapeutics (IOVA) Stock Rating Maintained, Price Target Lowered by Chardan Capital | IOVA Stock News - GuruFocus

Click here to get full coverage on Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Is Expected To Breakeven In The Near Future - Yahoo Finance

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Is Expected To Breakeven In The Near Future  Yahoo Finance

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Is Expected To Breakeven In The Near Future - Yahoo Finance

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Shares Plummet on Revenue Miss and Forecast Cut - GuruFocus

Iovance Biotherapeutics (IOVA) Shares Plummet on Revenue Miss and Forecast Cut  GuruFocus

Iovance Biotherapeutics (IOVA) Shares Plummet on Revenue Miss and Forecast Cut - GuruFocus

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Downgraded by JMP Securities | IOVA Stock News - GuruFocus

Iovance Biotherapeutics (IOVA) Downgraded by JMP Securities | IOVA Stock News  GuruFocus

Iovance Biotherapeutics (IOVA) Downgraded by JMP Securities | IOVA Stock News - GuruFocus

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Price Target Cut by TD Cowen | IOVA Stock News - GuruFocus

Iovance Biotherapeutics (IOVA) Price Target Cut by TD Cowen | IOVA Stock News  GuruFocus

Iovance Biotherapeutics (IOVA) Price Target Cut by TD Cowen | IOVA Stock News - GuruFocus

Click here to get full coverage on Why Iovance (IOVA) Stock Is Plummeting Today - GuruFocus

Why Iovance (IOVA) Stock Is Plummeting Today  GuruFocus

Why Iovance (IOVA) Stock Is Plummeting Today - GuruFocus

Click here to get full coverage on Earnings call transcript: Iovance Biotherapeutics misses Q1 2025 EPS forecasts, stock drops - Investing.com

Earnings call transcript: Iovance Biotherapeutics misses Q1 2025 EPS forecasts, stock drops  Investing.com

Earnings call transcript: Iovance Biotherapeutics misses Q1 2025 EPS forecasts, stock drops - Investing.com

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Price Target Cut Following Revised Revenue Outlook | IOVA Stock News - GuruFocus

Iovance Biotherapeutics (IOVA) Price Target Cut Following Revised Revenue Outlook | IOVA Stock News  GuruFocus

Iovance Biotherapeutics (IOVA) Price Target Cut Following Revised Revenue Outlook | IOVA Stock News - GuruFocus

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Price Target Lowered by HC Wainwright | IOVA Stock News - GuruFocus

Iovance Biotherapeutics (IOVA) Price Target Lowered by HC Wainwright | IOVA Stock News  GuruFocus

Iovance Biotherapeutics (IOVA) Price Target Lowered by HC Wainwright | IOVA Stock News - GuruFocus

Click here to get full coverage on Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi - Endpoints News

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi  Endpoints News

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi - Endpoints News

Click here to get full coverage on Iovance Biotherapeutics (NasdaqGM:IOVA) Sees 3% Price Increase Over Last Month - simplywall.st

Iovance Biotherapeutics (NasdaqGM:IOVA) Sees 3% Price Increase Over Last Month  simplywall.st

Iovance Biotherapeutics (NasdaqGM:IOVA) Sees 3% Price Increase Over Last Month - simplywall.st

Click here to get full coverage on Uncovering Potential: Iovance Biotherapeutics's Earnings Preview - Nasdaq

Uncovering Potential: Iovance Biotherapeutics's Earnings Preview  Nasdaq

Uncovering Potential: Iovance Biotherapeutics's Earnings Preview - Nasdaq

Click here to get full coverage on Iovance Biotherapeutics: Only For The Brave (NASDAQ:IOVA) - Seeking Alpha

Iovance Biotherapeutics: Only For The Brave (NASDAQ:IOVA)  Seeking Alpha

Iovance Biotherapeutics: Only For The Brave (NASDAQ:IOVA) - Seeking Alpha

Click here to get full coverage on (IOVA) Technical Data - news.stocktradersdaily.com

(IOVA) Technical Data  news.stocktradersdaily.com

(IOVA) Technical Data - news.stocktradersdaily.com

Click here to get full coverage on Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts? - Yahoo Finance

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?  Yahoo Finance

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts? - Yahoo Finance

Click here to get full coverage on Iovance Biotherapeutics earnings missed by $0.12, revenue fell short of estimates - Investing.com

Iovance Biotherapeutics earnings missed by $0.12, revenue fell short of estimates  Investing.com

Iovance Biotherapeutics earnings missed by $0.12, revenue fell short of estimates - Investing.com

Click here to get full coverage on Decoding Iovance Biotherapeutics Inc (IOVA): A Strategic SWOT Insight - GuruFocus

Decoding Iovance Biotherapeutics Inc (IOVA): A Strategic SWOT Insight  GuruFocus

Decoding Iovance Biotherapeutics Inc (IOVA): A Strategic SWOT Insight - GuruFocus

Click here to get full coverage on Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year. - Yahoo Finance

Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.  Yahoo Finance

Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year. - Yahoo Finance

Click here to get full coverage on Iovance (IOVA) Misses Q1 Revenue Expectations, Projects Growth in Q2 | IOVA Stock News - GuruFocus

Iovance (IOVA) Misses Q1 Revenue Expectations, Projects Growth in Q2 | IOVA Stock News  GuruFocus

Iovance (IOVA) Misses Q1 Revenue Expectations, Projects Growth in Q2 | IOVA Stock News - GuruFocus

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Q1 2025 Earnings Miss Estimates - GuruFocus

Iovance Biotherapeutics (IOVA) Q1 2025 Earnings Miss Estimates  GuruFocus

Iovance Biotherapeutics (IOVA) Q1 2025 Earnings Miss Estimates - GuruFocus

Click here to get full coverage on Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds?  Yahoo Finance

Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Projects Revenue Growth and Expanded Market Reach - GuruFocus

Iovance Biotherapeutics (IOVA) Projects Revenue Growth and Expanded Market Reach  GuruFocus

Iovance Biotherapeutics (IOVA) Projects Revenue Growth and Expanded Market Reach - GuruFocus

Click here to get full coverage on Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% on '25 View Cut - Yahoo Finance

Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% on '25 View Cut  Yahoo Finance

Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% on '25 View Cut - Yahoo Finance

Click here to get full coverage on Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday  Benzinga

Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

Click here to get full coverage on Iovance stock tumbles on Q1 revenue miss and guidance cut - Investing.com

Iovance stock tumbles on Q1 revenue miss and guidance cut  Investing.com

Iovance stock tumbles on Q1 revenue miss and guidance cut - Investing.com

Click here to get full coverage on This Biotech Stock Could Be the Best Investment of the Decade - The Motley Fool

This Biotech Stock Could Be the Best Investment of the Decade  The Motley Fool

This Biotech Stock Could Be the Best Investment of the Decade - The Motley Fool

Click here to get full coverage on Iovance Biotherapeutics: Q1 Earnings Snapshot - San Francisco Chronicle

Iovance Biotherapeutics: Q1 Earnings Snapshot  San Francisco Chronicle

Iovance Biotherapeutics: Q1 Earnings Snapshot - San Francisco Chronicle

Click here to get full coverage on IOVA Q4 Earnings Beat, Stock Down on Looming Economic Uncertainty - Yahoo Finance

IOVA Q4 Earnings Beat, Stock Down on Looming Economic Uncertainty  Yahoo Finance

IOVA Q4 Earnings Beat, Stock Down on Looming Economic Uncertainty - Yahoo Finance

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Projects Strong Growth with FDA-Approved Therapy - GuruFocus

Iovance Biotherapeutics (IOVA) Projects Strong Growth with FDA-Approved Therapy  GuruFocus

Iovance Biotherapeutics (IOVA) Projects Strong Growth with FDA-Approved Therapy - GuruFocus

Click here to get full coverage on Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) the Most Oversold Penny Stocks to Buy According to Analysts? - Yahoo Finance

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) the Most Oversold Penny Stocks to Buy According to Analysts?  Yahoo Finance

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) the Most Oversold Penny Stocks to Buy According to Analysts? - Yahoo Finance

Click here to get full coverage on Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Expected To Breakeven In The Medium-Term - simplywall.st

Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Expected To Breakeven In The Medium-Term  simplywall.st

Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Expected To Breakeven In The Medium-Term - simplywall.st

Click here to get full coverage on Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) The Top Penny Stock That Will Skyrocket? - Yahoo Finance

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) The Top Penny Stock That Will Skyrocket?  Yahoo Finance

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) The Top Penny Stock That Will Skyrocket? - Yahoo Finance

Click here to get full coverage on Is Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Yahoo Finance

Is Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?  Yahoo Finance

Is Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Yahoo Finance

Click here to get full coverage on Iovance Biotherapeutics (NasdaqGM:IOVA) Drops 10% Over The Week In Market Correction - Yahoo Finance

Iovance Biotherapeutics (NasdaqGM:IOVA) Drops 10% Over The Week In Market Correction  Yahoo Finance

Iovance Biotherapeutics (NasdaqGM:IOVA) Drops 10% Over The Week In Market Correction - Yahoo Finance

Click here to get full coverage on Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should Know  Yahoo Finance

Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

Click here to get full coverage on Iovance Biotherapeutics Inc (IOVA) Q4 2024 Earnings Call Highlights: Strong Revenue and ... - Yahoo Finance

Iovance Biotherapeutics Inc (IOVA) Q4 2024 Earnings Call Highlights: Strong Revenue and ...  Yahoo Finance

Iovance Biotherapeutics Inc (IOVA) Q4 2024 Earnings Call Highlights: Strong Revenue and ... - Yahoo Finance

Click here to get full coverage on Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Dips 27% Despite Reaffirmed 2025 Earnings Guidance - Yahoo Finance

Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Dips 27% Despite Reaffirmed 2025 Earnings Guidance  Yahoo Finance

Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Dips 27% Despite Reaffirmed 2025 Earnings Guidance - Yahoo Finance

Click here to get full coverage on Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates  Yahoo Finance

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on $IOVA stock is up 7% today. Here's what we see in our data. - Nasdaq

$IOVA stock is up 7% today. Here's what we see in our data.  Nasdaq

$IOVA stock is up 7% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on IOVANCE BIOTHERAPEUTICS, INC. SEC 10-Q Report - TradingView

IOVANCE BIOTHERAPEUTICS, INC. SEC 10-Q Report  TradingView

IOVANCE BIOTHERAPEUTICS, INC. SEC 10-Q Report - TradingView

Click here to get full coverage on Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% On '25 View Cut - Barchart.com

Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% On '25 View Cut  Barchart.com

Iovance Biotherapeutics Inc (IOVA)

Price Chart

Key Statistics

Technicals

About IOVA

Latest News

Iovance Biotherapeutics Inc (IOVA) Q1 2025 Earnings Call Highlights: Strong Revenue from Antagy ... - Yahoo Finance

No Excuses, Iovance Biotherapeutics' Amtagvi Launch Has Underperformed (NASDAQ:IOVA) - Seeking Alpha

Iovance Biotherapeutics Stock Sinks 46%. Here’s Why the Biotech Is Tumbling. - Barron's

Advanced Charts

Top Gainers

Top Losers